IBJ: First 16 Tech office building set to open in June; Innovation Hub to follow

2021-01-14T11:10:15-05:00March 9, 2020|

With the first 120,000 square foot building fully leased before construction is complete, the Indianapolis Business Journal looks at the 16 Tech Innovation District's upcoming first-phase completion success and the features that should bring established companies, startups and big thinkers to the Circle City’s highly anticipated innovation district. “This project has been a long time in the works, but now, with the construction and imminent opening of these first buildings, it’s becoming very real,” said 16 Tech CEO Bob Coy. “We’re starting to see a visual transformation, and with that happening momentum for this project is building and will feed on itself.” Learn what this project has in common with other similar and successful ventures around the country, and what makes the Indy endeavor unique.  [READ MORE]

IBJ: Mark Howell – Let’s Keep Indiana on Top of Advanced Manufacturing

2021-01-12T17:11:16-05:00July 22, 2019|

Mark Howell, president and CEO, Conexus Indiana Mark Howell, president and CEO of Conexus Indiana, the advanced manufacturing and logistics initiative of the Central Indiana Corporate Partnership (CICP), says a number of key companies including Allison Transmission, Cummins Inc. and General Motors Co. are part of an expanding list of advanced manufacturers that are embracing the new industrial revolution, also known as Industry 4.0.  Howell has more in a recent IBJ op-ed. [READ MORE] (Sources: IBJ, Conexus Indiana)

IBJ: Indiana life sciences companies raise record $115 million in venture capital

2021-01-14T12:07:35-05:00January 22, 2019|

The Indianapolis Business Journal's John Russell is reporting that Indiana life sciences companies raised $115 million in venture capital funding in 2018, a three percent jump from 2017 and 133 percent higher than 2015. “The thing that jumped out at me was the variety,” said Brian Stemme, who tracks venture deals for BioCrossroads (CICP's life sciences initiative), pointing to products under development ranging from cancer drugs to tele-health software. [READ MORE] (Sources: IBJ and BioCrossroads)

Go to Top